Get the Stockscreener App
5.97
9.68%
-0.64
After Hours:
6.41
0.44
+7.37%
Zhengye Biotechnology Holding Ltd stock is traded at $5.97, with a volume of 211.81K.
It is down -9.68% in the last 24 hours and down -33.81% over the past month.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.
See More
Previous Close:
$6.61
Open:
$6.71
24h Volume:
211.81K
Relative Volume:
0.36
Market Cap:
$296.20M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-19.60%
1M Performance:
-33.81%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$5.69
$7.2347
1-Week Range:
$5.69
$8.00
52-Week Range:
$3.50
$14.30
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Compare ZYBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
5.97 | 296.20M | 0 | 0 | 0 | 0.00 |
|
RGC
Regencell Bioscience Holdings Ltd
|
17.04 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
155.95 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.37 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.46 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.76 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Latest News
Zhengye Biotechnology (NASDAQ:ZYBT) Trading Down 6% – Time to Sell? - Defense World
Zhengye Biotechnology Receives NASDAQ Delinquency Notice for Late Filing - TipRanks
Zhengye Biotechnology faces NASDAQ compliance issue By Investing.com - Investing.com Nigeria
Zhengye Biotechnology faces NASDAQ compliance issue - Investing.com
Zhengye Biotechnology Holding Limited Receives NASDAQ Delinquency Letter for Non-Compliance with Listing Requirements - Nasdaq
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewswire
The Alternative Data Center Stocks Nobody Is Watching Right Now - Energy & Capital
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Tesla, Regeneron Among Market Cap Stock Movers on Wednesday - Investing.com Australia
Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Tesla, UnitedHealth Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
Zhengye Biotechnology Delays 20-F Filing - TipRanks
Spotify, Regeneron lead Tuesday’s market cap stock movers By Investing.com - Investing.com South Africa
Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
The Only Nuclear Stocks to Buy Today - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital
Understanding ZYBT stock ratios for better investment decisions - uspostnews.com
Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com
Chinese Fire Up Their Most Powerful Nuclear Plant - Energy & Capital
If You’re Not Buying Oil Stocks Right Now, Then You Hate Money. - Energy & Capital
Catherine De Noire Reveals Uncomfortable Truth: Prostitutes Make Excellent Financial Advisors - Energy & Capital
Gold Is The Place To Be... Or Is It? - Energy & Capital
Buy Oil NOW, Thank Me Later - Energy & Capital
Warren Buffett Was Right Again, Here’s What He’s Doing Next - Energy & Capital
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st
Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance
Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks
Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Kroger CEO Questions Remain While the Market Moves on - Energy & Capital
This Silver Stock Is Like No Other - Energy & Capital
Trump’s Only Solution to Low Energy Prices - Energy & Capital
Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Data Gusher: The AI Arms Race Has Begun - Energy & Capital
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Financials Data
There is no financial data for Zhengye Biotechnology Holding Ltd (ZYBT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.07%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):